Showing 121 - 140 of 361 results
The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program
Think Science! 2025 Summary and results
Recoil Time of Flight Spectrometry (RTOF) is used to detect a multitude of elements by separating their masses. unambiguously
ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.
The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.
Recommended accommodation and transport information.
Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.
Exploring the interaction of polystyrene nanoplastics and blood plasma proteins.
An unassuming rock shelter in the Flinders Ranges has been revealed as the oldest known evidence of Aboriginal Australian settlement, thanks in part to advanced nuclear techniques, technology and scientists.
ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.
Radiocarbon analyses on corals from two sites in Australian waters of the southwest (SW) Pacific has indicated significant changes in ocean circulation in the Pacific and large climate variability during the early to mid-Holocene period (8,000-5,400 years ago).
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.